Targeting of mannosylated liposome incorporated benzyl derivative of Penicillium nigricans derived compound MT81 to reticuloendothelial systems for the treatment of visceral leishmaniasis

Author： Mitra Maitreyi   Mandal Ardhendu K.   Chatterjee Tapan Kumar   Das Nirmalendu  

Publisher： Informa Healthcare

ISSN： 1061-186X

Source： Journal of Drug Targeting, Vol.13, Iss.5, 2005-06, pp. : 285-293

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Developments in the treatment of visceral leishmaniasis

By den Boer Margriet Leontine   Alvar Jorge   Davidson Robert N   Ritmeijer Koert   Balasegaram Manica  

Expert Opinion on Emerging Drugs, Vol. 14, Iss. 3, 2009-09 ,pp. : 395-410

Informa Healthcare

Access to resources Recommend Favorite

Treatment of visceral leishmaniasis

By Sundar Shyam   Rai Madhukar  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 16, 2005-12 ,pp. : 2821-2829

Informa Healthcare

Access to resources Recommend Favorite

Drug targeting to macrophages using paromomycin-loaded albumin microspheres for treatment of visceral leishmaniasis: an in vitro evaluation

By Khan Wahid   Kumar Neeraj  

Journal of Drug Targeting, Vol. 19, Iss. 4, 2011-05 ,pp. : 239-250

Informa Healthcare

Access to resources Recommend Favorite

Treatment of visceral leishmaniasis: a review of current treatment practices

By Rosenthal Eric   Marty Pierre  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 8, 2002-08 ,pp. : 1101-1108

Informa Healthcare

Access to resources Recommend Favorite

New treatment approach for visceral leishmaniasis active

By  

Inpharma, Vol. 1, Iss. 1659, 2008-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite